MPLT insider transactions
MapLight Therapeutics Inc. (MPLT) Form 4 insider transactions - real-time wire coverage of every officer, director, and 10% owner trade.
Recent Form 3, 4, and 5 filings for MPLT
- Chief Discovery Officer Kreitzer Anatol sold $1,345,894 worth of Voting Common Stock (36,284 units at $37.09) as part of a pre-agreed trading plan, decreasing direct ownership by 17% to 174,906 units (SEC Form 4) to cover withholding tax4 - MapLight Therapeutics, Inc. (0001770069) (Issuer)
- CAO and Interim CFO Gillis Jonathan sold $1,372,668 worth of Voting Common Stock (36,979 units at $37.12) as part of a pre-agreed trading plan, decreasing direct ownership by 20% to 144,240 units (SEC Form 4) to satisfy tax liability4 - MapLight Therapeutics, Inc. (0001770069) (Issuer)
- Chief Executive Officer Kroeger Christopher A. sold $5,443,722 worth of Voting Common Stock (147,639 units at $36.87), decreasing direct ownership by 11% to 1,246,455 units (SEC Form 4) to satisfy withholding obligation4 - MapLight Therapeutics, Inc. (0001770069) (Issuer)
- Chief Scientific Officer Lillie James Woodruff sold $673,636 worth of Voting Common Stock (18,267 units at $36.88), decreasing direct ownership by 8% to 224,462 units (SEC Form 4) to satisfy withholding obligation4 - MapLight Therapeutics, Inc. (0001770069) (Issuer)
- General Counsel Hanson Kristopher sold $607,870 worth of Voting Common Stock (16,508 units at $36.82), decreasing direct ownership by 10% to 145,823 units (SEC Form 4) to cover taxes4 - MapLight Therapeutics, Inc. (0001770069) (Issuer)
- Chief Medical Officer Foff Erin Pennock sold $1,734,490 worth of Voting Common Stock (47,158 units at $36.78) as part of a pre-agreed trading plan, decreasing direct ownership by 14% to 298,901 units (SEC Form 4) (withholding obligation)4 - MapLight Therapeutics, Inc. (0001770069) (Issuer)
- Director Cox Troy was granted 7,864 units of Voting Common Stock (SEC Form 4)4 - MapLight Therapeutics, Inc. (0001770069) (Issuer)
- Director Babler Martin was granted 7,864 units of Voting Common Stock (SEC Form 4)4 - MapLight Therapeutics, Inc. (0001770069) (Issuer)
- Director Garnett Timothy John was granted 3,932 units of Voting Common Stock, increasing direct ownership by 8% to 53,457 units (SEC Form 4)4 - MapLight Therapeutics, Inc. (0001770069) (Issuer)
- Director Luneborg Nanna Liebach was granted 3,932 units of Voting Common Stock (SEC Form 4)4 - MapLight Therapeutics, Inc. (0001770069) (Issuer)
- Director Pavlov George was granted 3,932 units of Voting Common Stock, increasing direct ownership by 16% to 28,932 units (SEC Form 4)4 - MapLight Therapeutics, Inc. (0001770069) (Issuer)
- Director Walker Maria C was granted 3,932 units of Voting Common Stock, increasing direct ownership by 7% to 62,703 units (SEC Form 4)4 - MapLight Therapeutics, Inc. (0001770069) (Issuer)
- SEC Form 3 filed by new insider Cox Troy3 - MapLight Therapeutics, Inc. (0001770069) (Issuer)
- SEC Form 3 filed by new insider Babler Martin3 - MapLight Therapeutics, Inc. (0001770069) (Issuer)
- Chief Executive Officer Kroeger Christopher A. sold $3,215,000 worth of Voting Common Stock (118,235 units at $27.19) as part of a pre-agreed trading plan, decreasing direct ownership by 8% to 1,394,094 units (SEC Form 4)4 - MapLight Therapeutics, Inc. (0001770069) (Issuer)
- Chief Medical Officer Foff Erin Pennock sold $126,640 worth of Voting Common Stock (4,438 units at $28.54) as part of a pre-agreed trading plan, decreasing direct ownership by 1% to 346,059 units (SEC Form 4)4 - MapLight Therapeutics, Inc. (0001770069) (Issuer)
- General Counsel Hanson Kristopher sold $419,263 worth of Voting Common Stock (13,917 units at $30.13) as part of a pre-agreed trading plan, decreasing direct ownership by 8% to 162,331 units (SEC Form 4)4 - MapLight Therapeutics, Inc. (0001770069) (Issuer)
- Chief Executive Officer Kroeger Christopher A. sold $1,949,634 worth of Voting Common Stock (68,491 units at $28.47) as part of a pre-agreed trading plan, decreasing direct ownership by 4% to 1,512,329 units (SEC Form 4)4 - MapLight Therapeutics, Inc. (0001770069) (Issuer)
- Chief Scientific Officer Lillie James Woodruff sold $20,390 worth of Voting Common Stock (721 units at $28.28) as part of a pre-agreed trading plan, decreasing direct ownership by 0.30% to 242,729 units (SEC Form 4)4 - MapLight Therapeutics, Inc. (0001770069) (Issuer)
- Chief Executive Officer Kroeger Christopher A. sold $1,412,235 worth of Voting Common Stock (49,744 units at $28.39) as part of a pre-agreed trading plan, decreasing direct ownership by 3% to 1,580,820 units (SEC Form 4)4 - MapLight Therapeutics, Inc. (0001770069) (Issuer)
- General Counsel Hanson Kristopher sold $388,177 worth of Voting Common Stock (13,917 units at $27.89) as part of a pre-agreed trading plan, decreasing direct ownership by 7% to 176,248 units (SEC Form 4)4 - MapLight Therapeutics, Inc. (0001770069) (Issuer)
- Chief Financial Officer Setia Vishwas sold $1,024,719 worth of Voting Common Stock (36,371 units at $28.17) as part of a pre-agreed trading plan, decreasing direct ownership by 9% to 356,256 units (SEC Form 4)4 - MapLight Therapeutics, Inc. (0001770069) (Issuer)
- Chief Medical Officer Foff Erin Pennock sold $1,427,594 worth of Voting Common Stock (50,280 units at $28.39) as part of a pre-agreed trading plan, decreasing direct ownership by 13% to 350,497 units (SEC Form 4)4 - MapLight Therapeutics, Inc. (0001770069) (Issuer)
- Chief Scientific Officer Lillie James Woodruff sold $1,468,251 worth of Voting Common Stock (51,707 units at $28.40) as part of a pre-agreed trading plan, decreasing direct ownership by 18% to 243,450 units (SEC Form 4)4 - MapLight Therapeutics, Inc. (0001770069) (Issuer)
- Chief Discovery Officer Kreitzer Anatol sold $1,347,066 worth of Voting Common Stock (45,422 units at $29.66) as part of a pre-agreed trading plan, decreasing direct ownership by 18% to 211,190 units (SEC Form 4)4 - MapLight Therapeutics, Inc. (0001770069) (Issuer)
- CAAO and PAO Gillis Jonathan sold $2,087,687 worth of Voting Common Stock (69,835 units at $29.89) as part of a pre-agreed trading plan, decreasing direct ownership by 28% to 181,219 units (SEC Form 4)4 - MapLight Therapeutics, Inc. (0001770069) (Issuer)
- SEC Form 4 filed by Foff Erin Pennock4 - MapLight Therapeutics, Inc. (0001770069) (Issuer)
- SEC Form 4 filed by Lillie James Woodruff4 - MapLight Therapeutics, Inc. (0001770069) (Issuer)
- SEC Form 4 filed by Hanson Kristopher4 - MapLight Therapeutics, Inc. (0001770069) (Issuer)
- SEC Form 4 filed by Gillis Jonathan4 - MapLight Therapeutics, Inc. (0001770069) (Issuer)
- SEC Form 4 filed by Kreitzer Anatol4 - MapLight Therapeutics, Inc. (0001770069) (Issuer)
- SEC Form 4 filed by Setia Vishwas4 - MapLight Therapeutics, Inc. (0001770069) (Issuer)
- SEC Form 4 filed by Kroeger Christopher A.4 - MapLight Therapeutics, Inc. (0001770069) (Issuer)
- SEC Form 4 filed by Malenka Robert C.4 - MapLight Therapeutics, Inc. (0001770069) (Issuer)
- Director Malenka Robert C. sold $260,398 worth of Voting Common Stock (14,195 units at $18.34), decreasing direct ownership by 4% to 325,059 units (SEC Form 4)4 - MapLight Therapeutics, Inc. (0001770069) (Issuer)
- Director Pavlov George bought $441,168 worth of Voting Common Stock (25,000 units at $17.65) (SEC Form 4)4 - MapLight Therapeutics, Inc. (0001770069) (Issuer)
- Director Malenka Robert C. sold $220,632 worth of Voting Common Stock (12,116 units at $18.21), decreasing direct ownership by 3% to 339,254 units (SEC Form 4)4 - MapLight Therapeutics, Inc. (0001770069) (Issuer)
- Director Malenka Robert C. sold $124,329 worth of Voting Common Stock (6,863 units at $18.12), decreasing direct ownership by 2% to 351,370 units (SEC Form 4)4 - MapLight Therapeutics, Inc. (0001770069) (Issuer)
- Director Garnett Timothy John bought $252,678 worth of Voting Common Stock (14,124 units at $17.89) (SEC Form 4)4 - MapLight Therapeutics, Inc. (0001770069) (Issuer)
- CAAO and PAO Gillis Jonathan was granted 6,020 units of Voting Common Stock, increasing direct ownership by 2% to 254,523 units (SEC Form 4)4 - MapLight Therapeutics, Inc. (0001770069) (Issuer)
- Chief Scientific Officer Lillie James Woodruff was granted 7,730 units of Voting Common Stock, increasing direct ownership by 3% to 298,862 units (SEC Form 4)4 - MapLight Therapeutics, Inc. (0001770069) (Issuer)
- Chief Financial Officer Setia Vishwas was granted 7,730 units of Voting Common Stock, increasing direct ownership by 2% to 395,549 units (SEC Form 4)4 - MapLight Therapeutics, Inc. (0001770069) (Issuer)
- Chief Discovery Officer Kreitzer Anatol was granted 6,020 units of Voting Common Stock, increasing direct ownership by 2% to 259,928 units (SEC Form 4)4 - MapLight Therapeutics, Inc. (0001770069) (Issuer)
- General Counsel Hanson Kristopher was granted 7,730 units of Voting Common Stock, increasing direct ownership by 4% to 191,582 units (SEC Form 4)4 - MapLight Therapeutics, Inc. (0001770069) (Issuer)
- Chief Executive Officer Kroeger Christopher A. was granted 23,145 units of Voting Common Stock, increasing direct ownership by 1% to 1,649,751 units (SEC Form 4)4 - MapLight Therapeutics, Inc. (0001770069) (Issuer)
- Chief Medical Officer Foff Erin Pennock was granted 13,360 units of Voting Common Stock, increasing direct ownership by 3% to 403,835 units (SEC Form 4)4 - MapLight Therapeutics, Inc. (0001770069) (Issuer)
- Director Malenka Robert C. sold $126,861 worth of Voting Common Stock (7,040 units at $18.02), decreasing direct ownership by 2% to 358,233 units (SEC Form 4)4 - MapLight Therapeutics, Inc. (0001770069) (Issuer)
- Director Malenka Robert C. sold $635,857 worth of Voting Common Stock (34,398 units at $18.49), decreasing direct ownership by 9% to 365,273 units (SEC Form 4)4 - MapLight Therapeutics, Inc. (0001770069) (Issuer)
- Chief Financial Officer Setia Vishwas covered exercise/tax liability with 33,382 units of Voting Common Stock, decreasing direct ownership by 8% to 387,819 units (SEC Form 4)4 - MapLight Therapeutics, Inc. (0001770069) (Issuer)
- CAAO and PAO Gillis Jonathan covered exercise/tax liability with 22,050 units of Voting Common Stock, decreasing direct ownership by 8% to 248,503 units (SEC Form 4)4 - MapLight Therapeutics, Inc. (0001770069) (Issuer)
- Chief Scientific Officer Lillie James Woodruff covered exercise/tax liability with 45,055 units of Voting Common Stock, decreasing direct ownership by 13% to 291,132 units (SEC Form 4)4 - MapLight Therapeutics, Inc. (0001770069) (Issuer)
- Chief Discovery Officer Kreitzer Anatol covered exercise/tax liability with 42,099 units of Voting Common Stock, decreasing direct ownership by 14% to 253,908 units (SEC Form 4)4 - MapLight Therapeutics, Inc. (0001770069) (Issuer)
- Chief Executive Officer Kroeger Christopher A. covered exercise/tax liability with 204,146 units of Voting Common Stock, decreasing direct ownership by 11% to 1,626,606 units (SEC Form 4)4 - MapLight Therapeutics, Inc. (0001770069) (Issuer)
- General Counsel Hanson Kristopher covered exercise/tax liability with 26,007 units of Voting Common Stock, decreasing direct ownership by 12% to 183,852 units (SEC Form 4)4 - MapLight Therapeutics, Inc. (0001770069) (Issuer)
- Chief Medical Officer Foff Erin Pennock covered exercise/tax liability with 44,616 units of Voting Common Stock, decreasing direct ownership by 10% to 390,475 units (SEC Form 4)4 - MapLight Therapeutics, Inc. (0001770069) (Issuer)
- Amendment: SEC Form 3 filed by new insider Pavlov George3/A - MapLight Therapeutics, Inc. (0001770069) (Issuer)
- Large owner Novo Holdings A/S converted options into 2,733,681 units of Voting Common Stock and bought $16,199,997 worth of Voting Common Stock (952,941 units at $17.00) (SEC Form 4)4 - MapLight Therapeutics, Inc. (0001770069) (Issuer)
- Large owner Catalyst4, Inc. converted options into 14,256,288 units of Voting Common Stock and bought $92,499,992 worth of Voting Common Stock (5,441,176 units at $17.00) (SEC Form 4)4 - MapLight Therapeutics, Inc. (0001770069) (Issuer)